Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
about
Progressive multifocal leukoencephalopathy: current treatment options and future perspectivesProgressive multifocal leukoencephalopathy: clinical and molecular aspectsProgressive multifocal leukoencephalopathy: new conceptsProgressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarateProgressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.Progressive Multifocal Leukoencephalopathy in HIV-Uninfected Individuals.Progressive multifocal leukoencephalopathy in HIV-1 infection.Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection.JC Virus Leuko-Encephalopathy in Reduced Intensity Conditioning Cord Blood Transplant Recipient with a Review of the Literature.Brain transcriptome-wide screen for HIV-1 Nef protein interaction partners reveals various membrane-associated proteinsProgressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment optionProgressive multifocal leukoencephalopathy associated with isolated CD8+ T-lymphocyte deficiency mimicking tumefactive MSImmunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceTherapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)5-HT2 receptors facilitate JC polyomavirus entry.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Progressive multifocal leukoencephalopathy: what's new?Safety considerations in drug treatment of depression in HIV-positive patients: an updated review.The link between VLA-4 and JC virus reactivation.HIV-associated neurological disorders: a guide to pharmacotherapy.Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics.Viral infections and their management in patients with chronic lymphocytic leukemia.Evaluation of progressive multifocal leukoencephalopathy treatments in a Spanish cohort of HIV-infected patients: do protease inhibitors improve survival regardless of central nervous system penetration-effectiveness (CPE) score?Multiple sclerosis treatment and infectious issues: update 2013.Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review.Risk of progressive multifocal leukoencephalopathy in patients with multiple sclerosis.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy?[Infection risks in multiple sclerosis therapy by infusion of disease modifying drugs].Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment.JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppressionFavourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient.Global HIV neurology: a comprehensive review.The Benefit of Mirtazapine in the Treatment of Progressive Multifocal Leukoencephalopathy in a Young HIV-positive Patient: A Case Report.
P2860
Q26776236-B3F1BDE1-43CB-4F4F-B435-F0A2B12FDDD7Q26858968-58D885F9-3283-4A6F-976D-77FF4EC0A575Q27016148-6278DBCA-3BC9-41FB-8AD9-8ABD336EB888Q28083338-89F3E46D-F84E-4F31-85A1-DA489C86C2F2Q30235523-DFF54D17-72EE-4561-A288-7BE3993FE623Q30245002-7CE57217-A4B4-41F0-B73B-095CF4848529Q33506561-41D97F57-D970-490E-B946-8C6BE3969C4AQ33893285-83815E1D-9A21-4086-A2A3-26429DDE1370Q34120884-295BD14C-45DE-4EE5-B175-63E99372E602Q34343528-7BF3C80D-8443-429A-A47F-EADE1D08B130Q34531994-3FB1EB67-4C41-46CD-BDB1-CC45FF23B362Q34816447-AE2E32D5-5106-4970-9029-A9E5C595C7D1Q35476415-C7551529-8EB8-4526-8207-7D83EFD23FC8Q36067334-FD5F775F-3832-4A60-A37E-D7C8DE22C304Q37180338-76D8C54B-B94E-43CE-AB66-691152B13E1AQ37336799-96F7D703-B0D0-4646-934B-A7BE8FF084D6Q37533880-6DC220FA-B47E-4774-A700-C9C903C2CCC5Q37755922-31563EEB-951F-4F4C-AB8B-152930BAFCECQ37900614-4B55625A-0EAA-4AB7-88FB-B131F8657B4EQ37965603-32C4368B-43FD-4879-A3D0-B02C991D3D4BQ37971469-9469B8A7-A007-444F-A650-53CC478A8D1AQ38007126-C2B8CC00-39C8-499C-9D7C-9A49CF64D7A2Q38064527-6A159A20-47EB-4142-85D7-C7A70B123ED0Q38065339-F57B75B2-B8D9-4BDC-B002-49DC4C885584Q38153471-DE3A2452-3CB3-4BB6-A01D-34FCCCF2AEB7Q38414352-74700C41-2291-440B-86C8-DD6117D7686EQ38591114-0DFFBC22-E155-4F9F-BCE6-F803A2EDAEF1Q38665891-1454FC15-8836-4DE9-81AF-3F49D52A1201Q39391443-695ED584-84E5-4836-B78A-AB64D9E39B75Q40039520-90EF2908-F44D-448D-B870-654D232C0279Q40133581-71F1AB42-3317-4E46-9ACC-8FB9C73F4F36Q41102105-37CA2F8B-50AE-4999-BEE4-BF5E9BAB314AQ41282310-8AEB8C6C-D7BB-4F10-8693-E8A5570F5B2BQ41921804-35AACF47-3B9A-4570-9964-F13372603477Q41921811-1070192A-4E27-4CA8-B3D1-1FA71AA07992Q42410099-D3EC40AA-B57B-4266-8490-C10A7286A175Q48395869-C35D663C-2D77-41C5-9781-32F7DE5AE13DQ51762497-8DC2152A-3C5A-4427-8B3A-AB904C3CE9B0Q54263542-E3031E24-4690-48EC-8866-00EE9033BEE2
P2860
Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@en
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@nl
type
label
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@en
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@nl
prefLabel
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@en
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@nl
P1433
P1476
Mirtazapine use in human immun ...... ultifocal leukoencephalopathy.
@en
P2093
Deanna Cettomai
Justin C McArthur
P304
P356
10.1001/ARCHNEUROL.2008.557
P577
2009-02-01T00:00:00Z